Pre-operative Carriage of Respiratory VIRUSes, and Acute Respiratory Distress Syndrome After Heart Surgery
VIRUS-ATTAC
1 other identifier
interventional
1,256
1 country
5
Brief Summary
The main objective of our study is to determine whether asymptomatic influenza virus carriage is associated with an increased risk of post-operative Acute Respiratory Distress Syndrome (ARDS) after cardiac surgery. Cardiac surgery patients are particularly at risk of developing ARDS with an estimated incidence of 5-10% based on the most recent data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2020
CompletedFirst Posted
Study publicly available on registry
September 24, 2020
CompletedStudy Start
First participant enrolled
February 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2023
CompletedMay 16, 2023
May 1, 2023
2 years
September 18, 2020
May 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of ARDS within 7 days after surgery related to influenza virus infection
Occurrence of ARDS in population with a positive test for influenza virus within 7 days after surgery according to Berlin criteria (PMID: 22797452)
7 days
Secondary Outcomes (4)
Occurrence of ARDS within 7 days after surgery related to respiratory virus infection
7 days
Postoperative respiratory complications
28 days
Morbidity
28 days
Mortality
28 days
Study Arms (1)
Patients
EXPERIMENTALAddition of a nasopharyngeal swab before surgery
Interventions
Nasopharyngeal swab for screening for respiratory virus infection before surgery
Eligibility Criteria
You may qualify if:
- Patients over 18 years of age ;
- Benefiting from cardiac surgery under extracorporeal circulation (ECC);
- Affiliated to a social security scheme;
- And having given free, informed and written consent
You may not qualify if:
- Admission for heart transplantation ;
- Admission for implantation of a left heart mechanical assist device or a total artificial heart;
- Patients with fever or flu-like symptoms during preoperative assessment (headache, myalgia, cough, nasal congestion, rhinorrhea)
- Patients participating in another clinical study that may interfere with the procedures in this study
- Persons of full age subject to legal protection (judicial protection, guardianship, trusteeship), persons deprived of their liberty, pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
APHP Henri Mondor
Créteil, France
CHU Nantes
Nantes, France
APHP La Pitié-Salpétrière
Paris, France
CHU Poitiers
Poitiers, France
CHU Rennes
Rennes, 35000, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas Nesseler, Md
Rennes University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2020
First Posted
September 24, 2020
Study Start
February 9, 2021
Primary Completion
February 10, 2023
Study Completion
March 10, 2023
Last Updated
May 16, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share